NO964903D0 - Substituerte benzendikarboksylsyre-diguanidid, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem - Google Patents

Substituerte benzendikarboksylsyre-diguanidid, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem

Info

Publication number
NO964903D0
NO964903D0 NO964903A NO964903A NO964903D0 NO 964903 D0 NO964903 D0 NO 964903D0 NO 964903 A NO964903 A NO 964903A NO 964903 A NO964903 A NO 964903A NO 964903 D0 NO964903 D0 NO 964903D0
Authority
NO
Norway
Prior art keywords
drug
diagnostic
preparation
well
benzenedicarboxylic acid
Prior art date
Application number
NO964903A
Other languages
English (en)
Inventor
Heinz-Werner Kleemann
Joachim Brendel
Jan-Robert Schwark
Andreas Weichert
Hans Jochen Lang
Udo Albus
Wolfgang Scholz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19543194A external-priority patent/DE19543194A1/de
Priority claimed from DE1996124064 external-priority patent/DE19624064A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO964903D0 publication Critical patent/NO964903D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO964903A 1995-11-20 1996-11-19 Substituerte benzendikarboksylsyre-diguanidid, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem NO964903D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19543194A DE19543194A1 (de) 1995-11-20 1995-11-20 Substituierte Benzoldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE1996124064 DE19624064A1 (de) 1996-06-17 1996-06-17 Substituierte Benzoldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
NO964903D0 true NO964903D0 (no) 1996-11-19

Family

ID=26020502

Family Applications (2)

Application Number Title Priority Date Filing Date
NO964905A NO964905L (no) 1995-11-20 1996-11-19 Substituerte benzendikarboksylsyre-diguanidider, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO964903A NO964903D0 (no) 1995-11-20 1996-11-19 Substituerte benzendikarboksylsyre-diguanidid, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO964905A NO964905L (no) 1995-11-20 1996-11-19 Substituerte benzendikarboksylsyre-diguanidider, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen

Country Status (18)

Country Link
EP (1) EP0774458A1 (no)
JP (1) JPH09169719A (no)
KR (1) KR980002018A (no)
AR (1) AR004331A1 (no)
AU (1) AU703352B2 (no)
BR (1) BR9605617A (no)
CA (1) CA2190693A1 (no)
CZ (1) CZ338296A3 (no)
HR (1) HRP960547A2 (no)
HU (1) HUP9603201A3 (no)
IL (1) IL119637A0 (no)
MX (1) MX9605674A (no)
NO (2) NO964905L (no)
NZ (1) NZ299772A (no)
PL (1) PL316438A1 (no)
SK (1) SK148796A3 (no)
TR (1) TR199600916A2 (no)
TW (1) TW353657B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819548A1 (de) * 1998-04-30 1999-11-04 Merck Patent Gmbh Biphenylderivate
DE10044732A1 (de) * 2000-09-09 2002-03-21 Mahle Ventiltrieb Gmbh Rollenstößel für einen Verbrennungsmotor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556674B1 (de) * 1992-02-15 1996-06-19 Hoechst Aktiengesellschaft 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen
IL109570A0 (en) 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IL114670A0 (en) * 1994-08-05 1995-11-27 Fujisawa Pharmaceutical Co Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof

Also Published As

Publication number Publication date
AU703352B2 (en) 1999-03-25
AR004331A1 (es) 1998-11-04
HUP9603201A3 (en) 1997-11-28
PL316438A1 (en) 1997-05-26
EP0774458A1 (de) 1997-05-21
JPH09169719A (ja) 1997-06-30
CZ338296A3 (cs) 1998-05-13
HU9603201D0 (en) 1997-01-28
HRP960547A2 (en) 1998-02-28
NO964905D0 (no) 1996-11-19
MX9605674A (es) 1997-05-31
NZ299772A (en) 1998-12-23
AU7180496A (en) 1997-05-29
KR980002018A (ko) 1998-03-30
CA2190693A1 (en) 1997-05-21
NO964905L (no) 1997-05-21
BR9605617A (pt) 1998-08-18
SK148796A3 (en) 1997-10-08
HUP9603201A2 (en) 1997-05-28
IL119637A0 (en) 1997-02-18
TW353657B (en) 1999-03-01
TR199600916A2 (tr) 1997-06-21

Similar Documents

Publication Publication Date Title
NO973850L (no) Fenylsubstituerte alkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostika såvel som medikamenter inneholdende dem
NO962063L (no) Fluorfenylsubstituerte alkenylkarboksylsyre-guanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem
NO964639L (no) Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO881164D0 (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
NO962006L (no) Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DK0723956T3 (da) Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
NO20022801D0 (no) Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse
DK0755919T3 (da) Substituerede kanelsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som hjerte-kredsløbs-medikament e
NO952596D0 (no) Orto-aminosubstituerte benzoylguandiner, fremgangsmåter for deres fremstilling, deres anvendelse som legemiddel eller diagnostikum såvel som medikamenter som inneholder dem
NO964053D0 (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO972433L (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO960627L (no) Substituerte benzolsulfonylurinstoffer, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt legemidler inneholdende dem
NO962999D0 (no) Fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum, såvel som medikament inneholdende dem
NO980694D0 (no) Sulfonamidsubstituerte kromaner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostika såvel som medikamenter inneholdende dem
DK1097140T3 (da) Imidazolderivater med biphenylsubstitution, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum og lægemiddel som indeholder dem
NO964903D0 (no) Substituerte benzendikarboksylsyre-diguanidid, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem
DK0411268T3 (da) Dibenzo(1,5)dioxocin-5-on-derivater, deres anvendelse i lægemidler og fremgangsmåde til deres fremstilling
NO964904D0 (no) Substituerte benzendikarboksylsyre-diguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikamenter inneholdende dem
NO983577L (no) Sulfonamidsubstituerte forbindelser, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen
NO954739D0 (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene
NO970697L (no) Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene
NO970406D0 (no) Substituerte diaryldikarboksylsyrediguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikamenter eller diagnostika såvel som medikamenter inneholdende dem
DK0791577T3 (da) Ortho-substituerede benzolguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnosti
NO970963L (no) Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene